Arca Biopharma | ABIO - Acreedores Comerciales





Acreedores Comerciales Cambio Fecha
Alterity Therapeutics Limited AUD 1.07M 203.72K 2025-12
Amgen USD 19.52B 1.37B 2026-03
Arca Biopharma USD 4.16M 1.95M 2025-12
Biogen USD 358.5M 73.5M 2026-03
Brainstorm Cell Therapeutics USD 7.32M 250K 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Capricor Therapeutics 3.93M 2.27M 2026-03
Cipla INR 32.3B 1.95B 2026-03
Clal Biotechnology ILS 21.05M 1.62M 2021-12
Compugen USD 2.35M 6.77M 2025-12
CSL USD 3.17B 290M 2025-12
Cytokinetics USD 24.71M 80.91M 2026-03
Daiichi Sankyo JPY 568.5B 16.84B 2025-12
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
Grifols EUR 987.75M 47.87M 2025-12
Laboratory Of America USD 695.7M 145.1M 2026-03
Myriad Genetics USD 32.6M 2.6M 2026-03
Otsuka Holdings JPY 196.04B 29.53B 2026-03
Pfizer USD 4.51B 734M 2026-03
United Therapeutics USD 498.3M 491.2M 2026-03